RootsAnalysis is pleased to announce the publication of its recent study, titled, “Nuclear Medicine andRadiopharmaceuticals Manufacturing Market, 2020-2030”
Thereport provides a detailed study on the current market landscape and future potentialof the companies having the capabilities to manufacture radiopharmaceuticals.In addition, the study features an in-depth analysis, highlighting thecapabilities of a diverse set of industry stakeholders. Amongst other elements,the report features the following:
· A detailed assessment of the current marketlandscape with respect to the players (industry and non-industry) involved inmanufacturing radiopharmaceuticals.
· An insightful four-dimensional comparison ofthe radiopharmaceutical manufacturers.
· Tabulated profiles of key industry playersbased in North America, Europe and Asia-Pacific (shortlisted based on thecompany size of the players).
· An analysis of recent partnerships andcollaborations inked in this domain since 2017.
· A detailed discussion on the supply chainmodel of medical isotope Mo-99 (Tc-99m).
KeyMarket Insights
· Close to 130 industry and non-industryplayers, across the globe, claim to have the necessary expertise and supportinginfrastructure to manufacture a wide variety of radioisotopes, for in-houseuse, or as a contract service
· The market is fragmented, featuring thepresence of companies in both developed and developing nations, which arecapable of manufacturing radiopharmaceuticals for various applications atdifferent scales of production
· The growing interest in this field isreflected in the yearly growth in partnership activity; the majority of dealsinked in the recent past include manufacturing and supply agreements forvarious types of radiopharmaceuticals
· Stakeholders are actively expanding their capabilitiesin order to enhance their respective nuclear medicine and radiopharmaceuticalmanufacturing capabilities and, thereby, maintain a competitive edge in thisindustry
· Case Study: The decay product of Mo-99,Tc-99m, is used in majority of the radioactivity-based diagnostic applicationsin the US; reactors in the European region alone contribute to 60% of theglobal production capacity
· In the long-term, the forecasted opportunityis anticipated to be higher for radioisotopes intended for diagnostic applications,mostly for use in the field of cardiology, with North America holding thedominant position
SPECT and beta-emitters areanticipated to generate the majority share of revenues across diagnostic andtherapeutic applications, respectively, for both in-house use andradiopharmaceutical supply contracts
Requestfor Customization:
Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)
TargetTherapeutic Area
· Cardiology
· Neurology
· Oncology
· Thyroid
· Others
ApplicationArea
· Diagnostic
· Therapeutic
Typeof Diagnostic Radiopharmaceuticals
· PET
· SPECT
Typeof Therapeutic Radiopharmaceuticals
· Alpha Emitters
· Beta Emitters
· Others
Purposeof Production
· In-House
· Outsourcing
KeyGeographical Region
· North America
· Europe
· Asia-Pacific and the Rest of the World
Transcriptsof interviews held with the following senior level representatives ofstakeholder companies
· J James Davis, Vice President Quality /R&D, Shertech Laboratories
· Andreas Fotopoulos, Professor of NuclearMedicine, University of Ioannina Medical School
· Jan Pruim, Professor of Medical Imaging /Nuclear Medicine Physician, University Medical Center of Groningen
· Michael van Dam, Professor, Crump Institutefor Molecular Imaging, Molecular & Medical Pharmacology
· Anonymous, ITM Isotopen Technologien München
Keycompanies covered in the report
· Advanced Accelerator Applications
· Belgian Nuclear Research Center (SCK•CEN)
· Cardinal Health
· China Isotope & Radiation Corporation
· Curium Pharma
· DuChemBio
· Eckert & Ziegler
· Eczacibasi-Monrol
· GE Healthcare
· Jubilant DraxImage
· Lantheus Medical Imaging
· Nihon Medi-Physics
· Nordion
· PETNET Solutions
· SinoTau Pharmaceuticals
· SOFIE
Requestfor Sample:
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
AlsoVisit Our Latest Publication
In Silico / Computer-Aided DrugDiscovery Services Market
Antibody Contract Manufacturing Market
Biopharma Contract Manufacturing Market
Cell Therapy Manufacturing Market
